| __timestamp | Insmed Incorporated | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31073000 | 1213000 |
| Thursday, January 1, 2015 | 43216000 | 3425000 |
| Friday, January 1, 2016 | 50679000 | 6311000 |
| Sunday, January 1, 2017 | 79171000 | 9518000 |
| Monday, January 1, 2018 | 168218000 | 28080000 |
| Tuesday, January 1, 2019 | 210796000 | 36550000 |
| Wednesday, January 1, 2020 | 203613000 | 46125000 |
| Friday, January 1, 2021 | 234273000 | 68486000 |
| Saturday, January 1, 2022 | 265784000 | 92032000 |
| Sunday, January 1, 2023 | 344501000 | 117532000 |
Unleashing the power of data
In the competitive landscape of biotechnology, Insmed Incorporated and Rhythm Pharmaceuticals, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses over the past decade. Since 2014, Insmed's SG&A expenses have surged by over 1,000%, reaching approximately $345 million in 2023. This growth reflects their aggressive expansion and investment in operational capabilities. In contrast, Rhythm Pharmaceuticals, Inc. has experienced a more moderate increase of around 9,600%, with expenses rising to about $118 million in the same period. This difference highlights varying strategic approaches, with Insmed focusing on rapid scaling and Rhythm maintaining a more measured pace. The data underscores the dynamic nature of the biotech sector, where financial strategies can significantly impact a company's market position. As these companies continue to evolve, their SG&A trends offer valuable insights into their operational priorities and future directions.
Cost Management Insights: SG&A Expenses for AbbVie Inc. and Rhythm Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Rhythm Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Viatris Inc. or Rhythm Pharmaceuticals, Inc.
Insmed Incorporated vs Halozyme Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Insmed Incorporated and Pharming Group N.V.
Insmed Incorporated and Opthea Limited: SG&A Spending Patterns Compared
Insmed Incorporated and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Walgreens Boots Alliance, Inc. and Rhythm Pharmaceuticals, Inc.
Verona Pharma plc and Rhythm Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Viking Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Bausch Health Companies Inc.
Cost Management Insights: SG&A Expenses for Rhythm Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.